We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
Abbott Diagnostics- Hematology Division

Randox Laboratories

  Gold Provides global diagnostic solutions for hospital laboratories, forensic laboratories, research laboratories, pharmac... read more Featured Products: More products

Download Mobile App




Events

ATTENTION: Due to the COVID-19 PANDEMIC, many events are being rescheduled for a later date, converted into virtual venues, or altogether cancelled. Please check with the event organizer or website prior to planning for any forthcoming event.

Urinary Biomarkers Predict Acute Kidney Injury in Patients with COVID-19

By LabMedica International staff writers
Posted on 08 Nov 2021
Print article
Image: The Randox RX Daytona clinical chemistry analyzer (Photo courtesy of BioAgilytix)
Image: The Randox RX Daytona clinical chemistry analyzer (Photo courtesy of BioAgilytix)
Acute kidney injury (AKI) is a sudden episode of kidney failure or kidney damage that happens within a few hours or a few days. AKI causes a build-up of waste products in the blood and makes it hard for the kidneys to keep the right balance of fluid in the body.

Biomarkers of kidney injury, inflammation, and repair may offer further insight beyond current standard methods of characterizing COVID-19-associated. Biomarkers can help to differentiate various types of kidney injury, and may be uniquely helpful in quantifying tubular injury in COVID-19.

Nephrologists at the Johns Hopkins University School of Medicine (Baltimore, MD, USA) and their colleagues collected urine samples after a patient’s admission with a confirmed COVID-19 test, with repeat urine sample collections attempted weekly thereafter for patients who remained hospitalized. The team analyzed data from 153 patients hospitalized with COVID-19 treated at two academic medical centers between April 2020 and June 2020.

The scientists selected nine candidate urinary biomarkers as primary exposure variables based on our prior work demonstrating associations of such biomarkers with adverse short and long-term kidney outcomes in other clinical settings. They additionally investigated the association of 10 inflammatory biomarkers with the primary outcome: urinary IL-1β, 2, 4, 6, 8, 10, 12, and 13; tumor necrosis factor alpha (TNF-α); and interferon-γ (IFN-γ).

Urine microscopy scoring was completed in a subset of 59 patients, using the IDEXX SediVue Dx platform (IDEXX Laboratories, Westbrook, ME, USA), with all 59 urine microscopy samples generating an automated report with 70 images each, which were reviewed manually. Urinary albumin and creatinine were measured using the Randox RX Daytona clinical chemistry analyzer (Randox, Crumlin, UK). All other biomarkers were measured using the Meso Scale Discovery (MSD, Rockville, MD, USA) platform.

The investigators reported a 2-fold higher levels of neutrophil gelatinase-associated lipocalin (NGAL), monocyte chemoattractant protein-1 (MCP-1), and kidney injury molecule-1 (KIM-1) were associated with increased risk of severe acute kidney injury or death in patients hospitalized with COVID-19. They also noted that subclinical AKI, defined by elevations in urinary biomarkers, was present in 30% to 50% of patients who did not manifest clinical AKI.

The authors concluded that they had identified significant associations between urinary NGAL, KIM-1, MCP-1, and EGF [epidermal growth factor] and the primary outcome of stage 3 AKI, requirement for dialysis, or death within 60 days of hospital admission. The discriminatory ability of the individual biomarkers EGF, NGAL, and MCP-1 alone was higher than that of urinary albumin alone and improved in pairwise combinations of these three biomarkers. Neither urine microscopy score nor the presence of viral RNA in the urine of patients with COVID-19 were associated with the primary outcome. The study was published on October 25, 2021 in the American Journal of Kidney Diseases.

Related Links:
Johns Hopkins University School of Medicine
IDEXX Laboratories
Randox
Meso Scale Discovery


New
Gold Supplier
Fully Automated Batch Immunoanalyzer
Evidence+
New
Clinical Chemistry Reagents
SEKURE Clinical Chemistry Reagents
New
Lateral Flow Test Cassette Reader
Quantum Blue III
New
Gold Supplier
TBI Blood Test
i-STAT TBI Plasma Test

Print article

Channels

Hematology

view channel
Image: Atellica Solution (Photo courtesy of Siemens Healthineers)

Siemens Introduces New Intelligent, Integrated IVD Solutions Virtually at EUROMEDLAB 2021

Siemens Healthineers (Erlangen, Germany) introduced new intelligent, integrated IVD solutions virtually at the XXIV IFCCEFLM European Congress of Clinical Chemistry and Laboratory Medicine (EuroMedLab... Read more

Immunology

view channel
Image: The Luminex 200 Instrument System sets the standard for multiplexing, providing the ability to perform up to 100 different tests in a single reaction volume on a flow cytometry-based platform (Photo courtesy of Luminex Corp)

Inflammatory Cytokines Measured in Infants Born to Preterm Preeclamptic Mothers

Preeclampsia is both a vascular and inflammatory disorder. The pathophysiology of preeclampsia is complex and rooted in the interplay between maternal and placental factors with the key characteristics... Read more

Microbiology

view channel
Image: The sciREADER CL2 enables high quality digital colorimetric imaging of various support formats (Photo courtesy of SCIENION)

Multiplex Immunoassay Developed for Confirmation and Typing of HTLV Infections

Human T-Cell Lymphotropic Viruses (HTLV) type 1 and type 2 account for an estimated five to 10 million infections worldwide and are transmitted through breast feeding, sexual contacts and contaminated... Read more

Pathology

view channel
Image: The Ventana BenchMark Ultra autostainer is for cancer diagnostics with automation and the test menu include IHC, ISH, and FITC tests (Photo courtesy of Ventana Medical System)

Specific Biomarker Investigated for Triple-Negative Breast Cancer Diagnosis

Triple-negative breast cancer (TNBC) is defined by the lack of estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor 2 (HER2) expression and comprises a heterogeneous... Read more

Technology

view channel
Image: PKeye Workflow Monitor System (Photo courtesy of PerkinElmer, Inc.)

PerkinElmer’s New Cloud-Based Platform Enables Laboratory Personnel to Remotely Manage Its Instruments in Real-Time

PerkinElmer, Inc. (Waltham, MA; USA) has launched its PKeye Workflow Monitor, a cloud-based platform enabling laboratory personnel to remotely manage and monitor their PerkinElmer instruments and workflows... Read more

Industry

view channel
Illustration

Global Lateral Flow Assay Market to Reach Nearly USD 6.5 Billion by 2031 Due to Surge in Demand for Rapid POC Testing

The global lateral flow assay market is projected to grow at a CAGR of around 5% from USD 3.7 billion in 2020 to over USD 6.4 billion by 2031, driven by the growing adoption of home-based lateral flow... Read more
Copyright © 2000-2021 Globetech Media. All rights reserved.